Do "Fixes" Fix Anything? Panel on Antitrust Remedies
5:30 PM EST
The adequacy of remedies in mergers and other antitrust matters has stirred a fair amount of debate. The work of John Kwoka has raised questions about whether partial divestitures or behavioral remedies have prevented supracompetitive prices post-merger, while the Federal Trade Commission's study of merger remedies found they were largely effective at maintaining competition. Assistant Attorney General Delrahim has indicated skepticism for behavioral remedies, and questions remain about partial divestitures. Three leading experts on antitrust remedies will present different points of view on the effectiveness of the antitrust agencies’ remedies and what the agencies should do going forward.
In-Person and Via-Telephone
1200 19th St. NW
Washington, DC 20036
5:30 p.m.ET: Panel discussion begins
6:30 p.m.ET: Refreshments and networking
FREE: Antitrust Section Members, Government, Non-profit Employees, Students.
$25 Other Non-Members
Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25. For this and all upcoming events visit http://ambar.org/atevents.
The ABA is not seeking CLE credit for this program.
Audio Archive: Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.